FDA Brief

Warning letters Drugs

FDA warning letter to

Hybrid Pharma, LLC

Issued Jun 7, 2022Posted Jun 14, 2022Office of Pharmaceutical Quality Operations, Division II

Compounding Pharmacy/Adulterated Drug Products. We haven't summarized this letter yet. Read it on fda.gov.